Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. A. Marzluf, K. Vonbank, B. Robibaro, B. Burian, C. Lambers, V. Petkov, P. Haber, L. H. Block (Vienna, Austria). P(a-et)CO2 at maximum exercise for early detection of pulmonary involvement in patients with sarcoidosis. Eur Respir J 2009; 34: Suppl. 53, 3651

Member's Comments

No comment yet.

Related content which might interest you: Endurance time is the most sensitive exercise measurement for evaluating pulmonary rehabilitation efficacy in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012 Clinical value of an abnormal increase of O2 pulse during early recovery from maximal exercise in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases Year: 2018 The radiographic stage and pulmonary function of patients with sarcoidosis Source: Annual Congress 2007 - Granulomatous lung diseases including sarcoidosis Year: 2007 Cardiopulmonary exercise testing for detection of early pulmonary vascular changes in relatives of patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007 The effect of pulmonary rehabilitation programme in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Rehabilitation, outcome measures and effects Year: 2011 Patients with chronic obstructive pulmonary disease benefit from a submaximal exercise intensity after a pulmonary rehabilitation programme Source: Annual Congress 2007 - Effects of training in rehabilitation Year: 2007 Pulmonary rehabilitation in patients with pulmonary sarcoidosis: impact on exercise capacity and fatigue. Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1 Year: 2020 Value of peak oxygen pulse for detection of cardiac comorbidities in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 The predictive value of inspiratory fraction to exercise capacity in patients with stable moderate to severe chronic obstructive pulmonary disease Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 Assessment of exercise capacity after lobectomy in patients with COPD Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007 The assessment of exercise capacity in chronic obstructive pulmonary disease patients Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005 Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Gas exchange impairment under incremental exercise in sarcoidosis patients with normal resting pulmonary functions Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange Year: 2008 Limiting factors at maximal exercise in sarcoidosis and idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 The pattern of improvement in endurance capacity during pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a pilot study Source: Eur Respir J 2002; 20: Suppl. 38, 66s Year: 2002 Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH Year: 2012 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 55 (6) 2000041; 10.1183/13993003.00041-2020 Year: 2020 Effectiveness of pulmonary rehabilitation on exercise capacity among different groups of patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017 The effect of pulmonary rehabilitation on expiratory flow limitation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Effects of training in rehabilitation Year: 2007